James River Asset Management LLC’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$82.8K Hold
30,000
– – 0.05% 88
2026
Q2
$69.9K Buy
+30,000
New +$63.5K 0.04% 89

Other funds holding PLX

James River Asset Management LLC's PLX Position: Q3 2026 in Review

James River Asset Management LLC held its Protalix BioTherapeutics (PLX) position steady in Q3 2026 at 30,000 shares worth $82.8K. The position accounts for 0.05% of the portfolio, ranked #88.

James River Asset Management LLC first reported a position in PLX in Q2 2026 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold PLX as of Q3 2026.

  • James River Asset Management LLC held 30,000 shares of Protalix BioTherapeutics worth $82.8K as of Q3 2026.
  • James River Asset Management LLC left its Protalix BioTherapeutics share count unchanged in Q3 2026.
  • Protalix BioTherapeutics made up 0.05% of James River Asset Management LLC's portfolio in Q3 2026, its #88 holding.
  • James River Asset Management LLC first reported a position in Protalix BioTherapeutics in Q2 2026 and has held it in 2 quarters since.
  • 100 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q3 2026.

Based on James River Asset Management LLC's 13F filing for Q3 2026, filed 16 Nov 2026.